Discovery Knows No Bounds

Discovery knows no bounds

© Copyright 2019 Regenerative Medicine Minnesota

2019 Biobusiness Development

2019 Biobusiness Development Awards

Vanesa Alonso Camino, PhD, Mill Creek Life Sciences
Development of Technology for the Large-scale Production of a Novel Dendritic Cell Vaccine for the Treatment of Glioblastoma

Frank Burton, PhD, Psyncretis, Inc.
Therapeutic & IP Optimization of Provisionally-Patented Anti-Inflammatory Wound-Healing Accelerant

Dominique Davidow, PhD, Miromatrix Medical Inc.
Automation of Cell Culture with a Terumo Quantum Cell Expansion System to Create Recellularized Bioengineered Whole Organs

Ohad Gafni, PhD, Recombinetics
Human Hematopoiesis in Genetically Modified Swine

Richard Murphy, Vascudyne Inc.
Development of Regenerative Engineered Tissue Embedded Cardiovascular Device

Timothy D. O'Brien, DVM, PhD, Superior Organoid Technologies, LLC
Development of Organoid-Derived Chondrocyte Products for Articular Cartilage Repair

Neil Otto, PhD, B-MoGen Biotechnologies
Amaxa LV Unit for Engineered Therapeutic Cells for Regenerative Medicine

Patrick Walsh, MS, Anatomi Corp.
Extending the Anatomi Corp Differentiation Ecosystem for the Production of hiPSC-Derived Neuronal Subtypes